Until early 2020 Seegene was a medium-sized S Korean purveyor of med diagnostics with c $110m in annual sales. It

Until early 2020 Seegene was a medium-sized S Korean purveyor of med diagnostics with c $110m in annual sales. It ended year with $1bn in sales & $440m in net profit thanks to its early COVID testing success. Can S Korea spawn a global biotech industry?
economist.com/business/2021/… https://t.co/T1T9v5WnnG

related posts